← Leaderboards
Robert Laird Judson-Torres
University Of California, San Francisco
$4,354,929
Attributed
$4,936,289
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $792.2K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,936,289 · 3
By mechanism
R01$2,989,457 · 2
DP5$1,946,832 · 1
Top collaborators
- Thomas Andrew Zangle3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Davide Ruggero$27,506,499
- Susana Ortiz Urda$610,200
- Alan Hunter Shain$5,305,683
- Jelena Levi$3,265,839
- Kyle David Halliwill$71,738
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMelanomaPreventSamplingNovel StrategiesMutationCellsMelanocyteLesionGrowthReportingMolecular ProfilingGeneticBraf GeneMicrornasAutomobile DrivingGenesEventDetectionRegulationSignal TransductionAreaIn VivoPre-Clinical
Grant awards (16)
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology$399,891
R01 · FY2025 · CA
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$348,844
R01 · FY2025 · CA · contact PI
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology$372,336
R01 · FY2024 · CA
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$331,402
R01 · FY2024 · CA · contact PI
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$54,037
R01 · FY2024 · CA · contact PI
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology$390,494
R01 · FY2023 · CA
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$341,867
R01 · FY2023 · CA · contact PI
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$59,875
R01 · FY2023 · CA · contact PI
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$341,867
R01 · FY2022 · CA · contact PI
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression$348,844
R01 · FY2021 · CA · contact PI
MicroRNA-Based Detection of Barriers to Melanoma Progression$255,703
DP5 · FY2018 · OD · contact PI
MicroRNA-Based Detection of Barriers to Melanoma Progression$130,487
DP5 · FY2018 · OD · contact PI
MicroRNA-Based Detection of Barriers to Melanoma Progression$396,250
DP5 · FY2017 · OD · contact PI
MicroRNA-Based Detection of Barriers to Melanoma Progression$390,400
DP5 · FY2016 · OD · contact PI
MicroRNA-Based Detection of Barriers to Melanoma Progression$390,400
DP5 · FY2015 · OD · contact PI
MicroRNA-Based Detection of Barriers to Melanoma Progression$383,592
DP5 · FY2014 · OD · contact PI